Genentech To Acquire AC Immune’s Beta-Amyloid Antibodies For Alzheimer’s Research
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech will pay more than $300 million for preclinical conformation-specific antibodies against beta-amyloid.